Meglimine Sodium Succinate

Meglimine Sodium Succinate · POLYSAN Scientific & Technological Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Meglimine Sodium Succinate, covering 2022-10-05 to 2022-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients [Phase 2]